Document is current
Any future updates will be listed below
-
Authors
Li, Chengxi
Callahan, Alex J.
Simon, Mark D.
Totaro, Kyle A.
Mijalis, Alexander J.
Phadke, Kruttika-Suhas
Zhang, Genwei
Hartrampf, Nina https://orcid.org/0000-0003-0875-6390
Schissel, Carly K.
Zhou, Ming
Zong, Hong
Hanson, Gunnar J.
Loas, Andrei
Pohl, Nicola L. B. https://orcid.org/0000-0001-7747-8983
Verhoeven, David E.
Pentelute, Bradley L. https://orcid.org/0000-0002-7242-801X
-
Funding
Funding for this research was provided by:
Koch Institute MIT School of Science Fellowship in Cancer Research
Sarepta Therapeutics, Inc.
- License Information
-
More Information
Article History
Received: 17 February 2021
Accepted: 11 June 2021
First Online: 20 July 2021
Competing interests
: B.L.P. is a co-founder of Amide Technologies and Resolute Bio. Both companies focus on the development of protein and peptide therapeutics. An international patent application covering part of this work has been filed by MIT and Sarepta Therapeutics (Int. Pat. Appl. WO2019060862A1). M.Z. and H.Z. are employees of Sarepta Therapeutics. K.A.T. is an employee of Amide Technologies. The authors declare no other competing interests.
